Filter
19
Featured
Language
Document type
No document type
12
Studies & Reports
4
Fact sheets
2
Resource Platforms
1
Countries / Regions
Kenya
1
Nigeria
1
Global
1
Western and Central Europe
1
Eastern Europe
1
Authors & Publishers
World Health Organization
7
World Health Organization WHO
3
PLOS One
2
C. C. Onyedum, I. Alobu, K. N. Ukwaja
1
C. M. Yuen, H. O. Weyenga, A. A. Kim, et al.
1
D. P. Chin, C. L. Hanson
1
ESDC
1
GBD 2019 Tuberculosis Collaborators
1
Global TB Programme: H. Getahun, MD, MPH, PhD.
1
IDSA
1
M. J. van der Werf, J. P. Zellweger
1
O. Neyrolles (Institut de Pharmacologie et de Biologoie Structurale)
1
Organisation mondiale de la Santé
1
Oxford, et al.
1
P. Glaziou, C.Sismanidis, P. J. Dodd, et al.
1
Stop TB Partnership
1
The Journal of Infectious Disease
1
UNAIDS
1
University of Sheffield
1
WHO
1
WHO Regional Office for Europe (WHO
1
Publication Years
Category
Countries
1
Policies & Guidelines HIV & TB
1
Studies & Reports
1
Statistics
1
Toolboxes
The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets. ... more
The World Health Organization Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and progress in the response, at global, regional and country levels. The 2022 edition features data on disease trends and the response to the epidemic from 215 countries and area... more
March 2022
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
Lancet Infect Dis 2022; 22: 222–4
Each year, the WHO Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets. The... more
October 2017
30 October 2017

Prevalence of drug-resistant tuberculosis in Nigeria: A systematic review and metaanalysis

C. C. Onyedum, I. Alobu, K. N. Ukwaja PLOS One; O. Neyrolles (Institut de Pharmacologie et de Biologoie Structurale) (2017) CC
PLoS ONE 12(7): e0180996. https://doi.org/10.1371/journal.pone.0180996
End TB. Accessed in November 2017.

Finding the Missing Tuberculosis Patients

D. P. Chin, C. L. Hanson The Journal of Infectious Disease; IDSA; Oxford, et al. (2017) C2
Supplement article The Journal of Infectious Diseases® 2017;216(S7):S675–8 DOI: 10.1093/infdis/jix368 Finding the Missing Tuberculosis Patients • JID 2017:216 (Suppl 7) • S675 Downloaded from https://academic.oup.com/jid/article-abstract/216/suppl_7/S675/4595547 by guest on 13 Nove... more
The dual epidemic of TB and Diabetes
Euro Surveill. 2016;21(12):pii=30174. DOI: http://dx.doi.org/10.2807/1560-7917.ES.2016.21.12.30174
Points saillants des 30 pays où la charge de la tuberculose est la plus Élevée. Pour mettre fin à la tuberculose.
Discussion paper initially prepared in April 2015 to facilitate feedback, and finalized after the June 2015 meeting of WHO’s Strategic and Technical Advisory Group for TB (STAG-TB).
PLoS ONE 9(6): e99880. doi:10.1371/journal.pone.0099880 Published June 17, 2014
WHO/HTM/TB/2012.9